1,996 results on '"Andrews, Nick"'
Search Results
52. Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England
53. GBS vaccines in the UK: a round table discussion
54. Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom
55. End of 2022/23 Season Influenza Vaccine Effectiveness in Primary Care in Great Britain
56. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
57. Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England
58. Transmission of SARS-CoV-2 in the household setting: A prospective cohort study in children and adults in England
59. Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
60. Mechanistic Differences in Neuropathic Pain Modalities Revealed by Correlating Behavior with Global Expression Profiling.
61. Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England
62. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study
63. Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial
64. Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers
65. Summary of evidence to reduce the two-dose infant priming schedule to a single dose of the 13-valent pneumococcal conjugate vaccine in the national immunisation programme in the UK
66. Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation
67. A Re-emergence of Subacute Sclerosing Panencephalitis in the United Kingdom
68. Characterising the Shape of Mathematics Teaching Decisions Made over Time: An Application of Tri-Polar Analysis
69. When Students Offer Explanations without the Teacher Explicitly Asking Them To
70. Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK
71. Quantifying and Adjusting for Confounding From Health-Seeking Behavior and Health Care Access in Observational Research.
72. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study
73. Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma
74. Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in England
75. Interlaboratory comparison of a multiplex immunoassay that measures human serum IgG antibodies against six-group B streptococcus polysaccharides
76. Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024
77. Antibody kinetics between birth and three months of life in healthy infants with natural exposure to Group B streptococcus: A UK cohort study
78. Effectiveness of Autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study.
79. Quantifying and adjusting for confounding from health-seeking behaviour and healthcare access in observational research.
80. Post-peak mpox in England: epidemiology, reinfection, and vaccine effectiveness. Data from 2023
81. Quantification of stimulus-evoked tactile allodynia in free moving mice by the chainmail sensitivity test
82. The risk of acute disseminated encephalomyelitis (ADEM) following covid-19 vaccination in England: A self-controlled case-series analysis
83. Ensuring transparency and minimization of methodologic bias in preclinical pain research: PPRECISE considerations.
84. The Use of Quasi-experimental Designs for Vaccine Evaluation
85. The Story of Georgie Muscles: A Narrative Approach to Nurturing Well-Being and Evidence-Enriched Practice in Health and Social Care
86. (17-010) Environment Protection Authority v Custom Chemicals Pty Ltd [2016] NSWLEC 146
87. (17-011) Council of the City of Sydney v NFF at 410 Pitt Street Pty Ltd [2016] NSWLEC 149
88. UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records
89. Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
90. A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infants
91. The role of mathematical vocabulary in moving from the particular to the general with visual representations
92. Real-world Effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S Vaccines Against SARS-CoV-2 in Solid Organ and Islet Transplant Recipients
93. Serocorrelates of protection against infant group B streptococcus disease
94. Effectiveness of oral rotavirus vaccination in England against rotavirus-confirmed and all-cause acute gastroenteritis
95. Composite Pain Biomarker Signatures for Objective Assessment and Effective Treatment
96. Association between COVID-19 Vaccination and SARS-CoV-2 Infection among Household Contacts of Infected Individuals: A Prospective Household Study in England
97. Going DEEP: an evaluation of a social pedagogy-informed approach to evidence-enriched practice in social care
98. Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort
99. Erratum to “Risk of cardiac arrhythmia and cardiac arrest after primary and booster COVID-19 vaccination in England: A self-controlled case series analysis” [Vaccine: X 15 (2023) 100418]
100. Oral fluid testing facilitates understanding of hepatitis A virus household transmission
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.